Literature DB >> 4629329

Platelet shape change and aggregation.

J P Caen, H Michel.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4629329     DOI： 10.1038/240148a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  [Failure of platelet spreading in thrombasthenia due to changes of high molecular weight membrane glycopeptides (author's transl)].

Authors:  B Podolsak; D Brunswig
Journal:  Klin Wochenschr       Date:  1976-07-01

2.  Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics.

Authors:  M Hatmi; B Haye; J M Gavaret; B B Vargaftig; C Jacquemin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.

Authors:  G de Gaetano; V Bertelé
Journal:  Agents Actions       Date:  1984-01

4.  A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.

Authors:  F Michal; M Motamed
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.